Image

“Why did the F.D.A. allow this huge push for the creation and the selling of ‘aging is optional for men,’ when we don’t know the benefits or harms?” asks Dartmouth’s Lisa Schwartz in a New York Times story about an expert panel’s recommendation to the Food and Drug Administration to impose stricter limitations within the testosterone drug industry.

Schwartz is a professor of medicine and of community and family medicine at the Geisel School of Medicine and a professor at The Dartmouth Institute for Health Policy & Clinical Practice.